Page last updated: 2024-08-05 10:47:54

sulfoxide

An organosulfur compound having the structure R2S=O or R2C=S=O (R =/= H).

ChEBI ID: 22063

Members (40)

MemberDefinitionRole
2-(2-phenoxyethylsulfonyl)-1H-benzimidazole2-(2-phenoxyethylsulfonyl)-1H-benzimidazole
4-(4-chlorophenyl)sulfinyl-6-(methoxymethyl)-2-methylpyrimidine4-(4-chlorophenyl)sulfinyl-6-(methoxymethyl)-2-methylpyrimidine
5-hydroxymethylomeprazoleA sulfoxide that is omeprazole in which one of the methyl hydrogens at position 5 on the pyridine ring is substituted by a hydroxy group.5'-hydroxyomeprazole
6-methylsulfinylhexyl isothiocyanate1-isothiocyanato-6-(methylsulfinyl)hexane
ajoene(E)-Ajoene
albendazole sulfoxidealbendazole S-oxide
allicinallicin
alyssin1-isothiocyanato-5-(methylsulfinyl)pentane
cenicrivirocA member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH).cenicriviroc
cimetidine sulfoxidecimetidine S-oxide
d-biotin-d-sulfoxideA sulfoxide that is the S-oxide of biotin.biotin sulfoxide
dexlansoprazoledexlansoprazole
dimethyl sulfoxideA 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.dimethyl sulfoxide
diphenyl sulfoxideDiphenyl sulfoxide
esomeprazole magnesiummagnesium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]benzimidazol-1-ide
fensulfothionfensulfothion
fipronilA member of the class of pyrazoles that is 1H-pyrazole that is substituted at positions 1, 3, 4, and 5 by 2,6-dichloro-4-(trifluoromethyl)phenyl, cyano, (trifluoromethyl)sulfinyl, and amino groups, respectively.5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile
fulvestrantA 3-hydroxy steroid that is 17beta-estradiol in which the 7alpha hydrogen has been replaced by a nonyl group in which one of the hydrogens of the terminal methyl has been replaced by a (4,4,5,5,5-pentafluoropentyl)sulfinyl group. An estrogen receptor antagonist, it is used in the treatment of breast cancer.fulvestrant
glucoraphaninA thia-glucosinolic acid that is glucoerucin in which the sulfur atom of the methyl thioether group has been oxidised to the corresponding sulfoxide.glucoraphanin
iberinAn isothiocyanate that is 1-isothiocyanatopropane in which a hydrogen at position 3 has been replaced by a methylsulfinyl group. A glucosinolate hydrolysis product found in many members of the Brassicaceae family, it is a quorum-sensing inhibitor (QSI) of the bacterial pathogen Pseudomonas aeruginosa.iberin
ilaprazoleilaprazole
lansoprazolelansoprazole
mesoridazineA phenothiazine substituted at position 2 (para to the S atom) by a methylsulfinyl group, and on the nitrogen by a 2-(1-methylpiperidin-2-yl)ethyl group.mesoridazine
methiocarb sulfoxideA carbamate ester obtained by the formal condensation of the phenolic group of 3,5-dimethyl-4-(methylsulfinyl)phenol with the carboxy group of methylcarbamic acid. It is a metabolite of the pesticide methiocarb.methiocarb-sulfoxide
methyl phenyl sulfoxideA sulfoxide resulting from the formal oxidation of the sulfur atom of thioanisole.(methylsulfinyl)benzene
modafinilA sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.2-[(diphenylmethyl)sulfinyl]acetamide
omeprazoleA member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole
omeprazole5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole
omeprazole magnesiummagnesium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]benzimidazol-1-ide
omeprazole sulfoneOmeprazole sulfone
oxfendazoleA member of the class of benzimidazoles that is fenbendazole in which the sulfur has been oxidised to the corresponding sulfoxide.oxfendazole
pantoprazoleA member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.pantoprazole
rabeprazolerabeprazole
ro 106-99206-(benzenesulfinyl)tetrazolo[1,5-b]pyridazine
sb 203580A member of the class of imidazoles carrying 4-methylsulfinylphenyl, 4-pyridyl and 4-fluorophenyl substituents at positions 2, 4 and 5 respectively. An inhibitor of mitogen-activated protein kinase.SB 203580
sulfinpyrazonesulfinpyrazone
sulforaphaneAn isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.sulforaphane
sulindacA monocarboxylic acid that is 1-benzylidene-1H-indene which is substituted at positions 2, 3, and 5 by methyl, carboxymethyl, and fluorine respectively, and in which the phenyl group of the benzylidene moiety is substituted at the para position by a methylsulfinyl group. It is a prodrug for the corresponding sulfide, a non-steroidal anti-inflammatory drug, used particularly in the treatment of acute and chronic inflammatory conditions.sulindac
sulmazoleAn imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardiotonic agent.sulmazole
ustiloxin bA heterodetic cyclic peptide with formula C26H39N5O12S produced by Ustilaginoidea virens fungi. It is an inhibitor of microtubule assembly.ustiloxin B

Research

Studies (39,623)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19908,109 (20.47)18.7374
1990's6,916 (17.45)18.2507
2000's11,261 (28.42)29.6817
2010's10,355 (26.13)24.3611
2020's2,982 (7.53)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials6,131 (13.59%)5.53%
Reviews2,941 (6.52%)6.00%
Case Studies2,211 (4.90%)4.05%
Observational68 (0.15%)0.25%
Other33,769 (74.84%)84.16%